24 results on '"Trylesinski, Aldo"'
Search Results
2. Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis
3. Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance
4. Long-Term Telbivudine Treatment Results in Resolution of Liver Inflammation and Fibrosis in Patients with Chronic Hepatitis B
5. Early Viral Kinetics with Telbivudine, Tenofovir or Combination of Both in Immunotolerant Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B
6. Two-year results of a randomized, phase III comparative trial of telbivudine versus lamivudine in Chinese patients
7. Telbivudine in combination with adefovir versus adefovir monotherapy in HBeAg-positive, lamivudine-resistant chronic hepatitis B
8. Knowledge of liver fibrosis stage among adults with NAFLD/NASH improves adherence to lifestyle changes.
9. A randomized trial of two-drug versus three-drug tenofovir-containing maintenance regimens in virologically controlled HIV-1 patients
10. Adefovir dipivoxil is effective for the treatment of cirrhotic patients with lamivudine failure
11. Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients
12. Risk factors for CD4 lymphopenia in patients treated with a tenofovir/didanosine high dose-containing highly active antiretroviral therapy regimen
13. 52-Week Efficacy and Safety of Telbivudine with Conditional Tenofovir Intensification at Week 24 in HBeAg-Positive Chronic Hepatitis B.
14. Pharmacokinetics and Resistance Mutations Affect Virologic Response to Ritonavir/Saquinavir-Containing Regimens.
15. Effect of Highly Active Antiretroviral Therapy on Expression of Interleukin-10 and Interleukin-12 in HIV-Infected Patients.
16. Telbivudine Improves Renal Function in Patients With Chronic Hepatitis B.
17. WED-296 PLIN2 is a specific marker for liver related disease.
18. Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events.
19. WED-215 HeparDx™ (by Metadeq, Inc.) is a reliable biomarker-based non-invasive test for MASH, capable of detecting the presence of inflammation and ballooning.
20. Non-invasive evaluation of response to obeticholic acid in patients with NASH: Results from the REGENERATE study.
21. Nelfinavir-induced urticaria and successful desensitization
22. Comparative Selection of the K65R and M184V/I Mutations in Human Immunodeficiency Virus Type 1-Infected Patients Enrolled in a Trial of First-Line Triple-Nucleoside Analog Therapy (Tonus IMEA 021).
23. FRI180 - Efficacy and tolerance of obeticholic acid in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid in real life: interim analysis of the OCARELIFE study.
24. THU048 - The burden of disease associated with non-alcoholic steatohepatitis patients under standard of care.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.